Aceragen | Credores Comerciais



Trade Creditors Alterar Data
Abbott USD 4.21B 7.48B 2025-03
Alnylam Pharmaceuticals USD 97.4M 8.98M 2025-03
Amgen USD 2.41B 498M 2025-03
Biogen USD 391.5M 32.7M 2025-03
BioMarin Pharmaceutical 235.4M 480.26M 2024-12
Cipla INR 28.37B 1.62B 2025-03
Clal Biotechnology ILS 21.05M 1.62M 2021-12
Compugen USD 1.84M 540K 2024-12
CSL USD 2.98B 2.11B 2024-12
Dynavax Technologies USD 4.33M 4.73M 2025-03
Eli Lilly USD 3.44B 213.4M 2025-03
Gilead Sciences USD 833M 70M 2024-12
GlaxoSmithKline 15.15B 186M 2025-03
Grifols EUR 852.3M 25.42M 2024-12
Merck USD 3.78B 295M 2025-03
Pfizer USD 5.24B 393M 2025-03
Roche Holding 4.35B 828M 2024-12
Sarepta Therapeutics USD 156.1M 58.34M 2025-03
Ultragenyx Pharmaceutical USD 38.76M 2.77M 2024-12
X T L Biopharmaceuticals 196K 358K 2024-12



Aceragen Credores Comerciais - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Jul 2025.